National Institutes of Health (NIH)
Bethesda
MD
United States
332 articles about National Institutes of Health (NIH)
-
PsychoGenics’ High Data Security Standards Are Certified by The NIH
1/12/2022
PsychoGenics Inc. announced that the National Institutes of Health (NIH) has completed the assessment of PsychoGenics data/IT security standards and systems, and gave official authority to operate as a government contractor.
-
Seattle-based Sana Biotechnology went all-in on improving CAR T therapies against B cell cancers in two separate deals announced today.
-
Sana Biotechnology Obtains Exclusive License from National Institutes of Health for CD22 CAR Construct
1/11/2022
Sana Biotechnology, Inc. announced that the company entered into an agreement with the National Cancer Institution, an institute of the National Institutes of Health, for worldwide exclusive commercial rights to the NIH’s CD22 chimeric antigen receptor with a fully-human binder for use in certain in vivo gene therapy and ex vivo allogeneic CAR T applications for B cell malignancies.
-
This California biotech just bagged another partner for its endeavor to cure autoimmune disease with cell therapy.
-
Dr. Charles Lieber was convicted Tuesday by a federal jury after being found guilty of lying to the U.S. government about his questionable ties with the People's Republic of China.
-
Moderna has decided to drop the patent application to "allow more time for discussions with the NIH”, which will be aimed at an amicable resolution.
-
As the spread of the Omicron variant of COVID-19 picks up speed, vaccine makers are rushing to test their shots against the new mutation, with mixed results.
-
Known as the Reproducibility Project: Cancer Biology, it spent eight years replicating experiments from high-impact cancer biology papers published between 2010 and 2012.
-
ATCC Announces Award from National Institute of Allergy and Infectious Diseases (NIAID) to Develop Research Capabilities in Infectious, Immunologic and Allergic Diseases
11/23/2021
ATCC, the world’s premier biological materials management and standards organization, announced that it has been awarded a seven-year, Indefinite Delivery/Indefinite Quantity contract with a ceiling value of $545 million by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
-
Boston Children's Hospital to co-lead a 25-center NIH-funded study of brain development from birth to age 10
11/17/2021
Study will investigate how a broad range of exposures affect brain and child development.
-
Delpor Advances Pipeline to Include Spasticity Maintenance Therapy with $2.5 Million NIH Grant for Tizanidine Implant
11/16/2021
Delpor, Inc., a clinical stage biopharmaceutical company that utilizes innovative technologies to develop once-yearly therapies for chronic conditions, announced an NIH grant award of $2.5 million for the further advancement of the company’s tizanidine implant product for moderate-severe spasticity.
-
Researchers have published a study of a woman being called the "Esperanza patient," one of what researchers call "elite controllers," who seem to eradicate HIV naturally.
-
HSS Scientist Awarded Two NIH Grants Totaling $6 Million
11/11/2021
A scientist at Hospital for Special Surgery, Chitra Dahia, PhD, has received two National Institutes of Health grants totaling $6 million for translational research aimed at understanding the root cause of disc degeneration and chronic back pain in order to develop treatment options that do not rely on addictive pain-relieving medications.
-
Texas Based 4E Therapeutics Awarded National Institutes of Health Research Grant to Develop Non-Opioid Treatment for Pain to End Addiction
11/10/2021
4E Therapeutics, Inc. announced that it has been awarded a $5.5 million Phase 2 National Institutes of Health (NIH) Small Business Innovation Research (SBIR) UG3 grant as part of the NIH Helping to End Addiction Long-Term (HEAL) Initiative.
-
Virpax Advances Envelta™ Development with NCATS Under CRADA Agreement
11/10/2021
Virpax® Pharmaceuticals, Inc. announced that the National Center for Advancing Translational Sciences at the National Institutes of Health has awarded research and development contracts to support Good Manufacturing Practices production of drug substance and drug product.
-
Public Citizen urged NIH director Dr. Francis Collins to clarify the NIH's role in Moderna's vaccine publicly and explain what he plans to ensure that federal scientists are credited for their work.
-
DNA Script to Develop Next Generation of Enzymatic DNA Synthesis Printers with $2.2 Million Grant Award from the National Human Genome Research Institute of the NIH
11/9/2021
DNA Script, a leader in benchtop enzymatic DNA synthesis, announced that the company has received a $2.2 million grant award from the National Human Genome Research Institute of the National Institutes of Health to support the ongoing development of next generation printers to enzymatically print synthetic DNA and RNA as a follow-on to their recently launched SYNTAX System.
-
The National Institutes of Health has removed a notice aimed at encouraging grant proposals from minority scientists from three separate institutes.
-
Mustang Bio Awarded NIH Grant For MB-106 CD20-Targeted CAR T Cell Therapy for Treatment of B-cell non-Hodgkin Lymphomas
11/1/2021
Mustang Bio, Inc. today announced that the company has been awarded a grant of approximately $2 million from the National Cancer Institute of the National Institutes of Health (“NIH”).
-
The Lundquist Institute Receives $3 Million From NIH To Expand Male Contraception Study
10/27/2021
The Lundquist Institute announced that its Male Contraceptive Efficacy Trial has received an additional $3 million from the National Institutes of Health to expand its work and recruit 120+ more couples.